← Russell 3000 cross-section

VMD VIEMED HEALTHCARE, INC.

Trailing twelve months to 2026-06-30 · as filed 2026-08-03, not restated
Healthcare

Scale

Market cap
$352m
Revenue TTM
$302m
Net income TTM
$14m
Free cash flow
$29m
Composite score
71.2
Sector rank
#2580

Valuation

P / E
24.3
EV / EBITDA
6.6
EV / sales
1.2
FCF yield
8.30%
Earnings yield vs 10-yr
-0.61pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
4.8%
EBITDA margin
17.6%
ROE
10.1%
ROIC
16.3%
Revenue growth
25.2%

Insider activity, last 90 days

Net open-market
$-0.35m
Buyers
0
Sellers
2

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We derive a significant portion of our revenue through the rental of non-invasive and invasive ventilators which represented 46.6% and 53.6% of our revenue for the three months ended June 30, 2026 and 2025, respectively, and 46.8% and 54.0% for the six months ended June 30, 2026 and 2025, respectively. Results of Operations Comparison of the Three Months Ended June 30, 2026 and 2025: The following table summarizes our results of operations for the three months ended June 30, 2026 and 2025: Revenue The following table summarizes our revenue for the three months ended June 30, 2026 and 2025: For the three months ended June 30, 2026, total revenue was $78.1 million, an increase of $15.0 million …VIEMED HEALTHCARE, INC., 10-Q, period ended 2026-06-30, filed 2026-08-03

Read the full passage →